title: A national audit on the management of pelvic inflammatory disease in UK genitourinary medicine clinics.
abstract: The prompt and effective treatment of pelvic inflammatory disease (PID) may reduce the risk of complications such as infertility, ectopic pregnancy and pelvic pain. We conducted a national audit to investigate the treatment of women diagnosed with PID and associated rates of partner notification in genitourinary (GU) medicine clinics during 2008 and compared our results with the British Association of Sexual Health and HIV (BASHH) 2005 national guideline. Among a total of 1,105,587 female attendees, national data showed 18,421 cases of PID diagnosed in GU medicine clinics, giving an incidence of 167 cases per 10,000 attendences. We audited a national sample of 1132 PID cases for review. Of those, 504 (44.5%) received a recommended treatment regimen and 447 (39%) of named male contacts were treated. Adherence to recommended treatment and partner notification did not reach national standards.
authors.affiliation: Department of GU Medicine, Chalmers Sexual Health Clinic, Edinburgh, UK. carlos.oroz@luht.scot.nhs.uk
authors.forename: C
authors.initials: C
authors.lastname: Oroz
authors.forename: H
authors.initials: H
authors.lastname: Bailey
authors.forename: K
authors.initials: K
authors.lastname: Hollows
authors.forename: J
authors.initials: J
authors.lastname: Lee
authors.forename: H
authors.initials: H
authors.lastname: Mullan
authors.forename: N
authors.initials: N
authors.lastname: Theobald
mesh_terms: D000890:Anti-Infective Agents / Q000627:therapeutic use; D016358:Contact Tracing; D005260:Female; D019983:Guideline Adherence / Q000592:standards / Q000706:statistics & numerical data*; D006176:Gynecology; D006801:Humans; D008297:Male; D008485:Medical Audit / Q000706:statistics & numerical data*; D000292:Pelvic Inflammatory Disease / Q000188:drug therapy* / Q000453:epidemiology*; D017410:Practice Guidelines as Topic; D006113:United Kingdom / Q000453:epidemiology
chemical_list: D000890:Anti-Infective Agents